Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0720

+2.9%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: boomertree2	10/29/2014 8:28:50 AM
	of 13111

SEC Insider-Trading Probe Centers On CMS. The Wall Street Journal (10/29, A1, Mullins, Pulliam, Weaver, Subscription Publication) reports in a front-page story that the Securities and Exchange Commission is conducting three overlapping insider-trading probes involving the Centers for Medicare and Medicaid Services, which together represent one of the largest investigations into leaks of government information to Wall Street. In one probe, the SEC is reviewing whether any CMS officials tipped off policy-research firm Marwood Group LLC about the agency’s review of Dendreon Corp.’s prostate-cancer treatment, according to people familiar with the investigation. The SEC and the FBI are also examining whether CMS officials leaked information about an increase in funding for health-insurance companies before it was made public in April 2013.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next